The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.
A bipartisan group of Republicans and Democrats support including the pro-China trade provision in the Senate USICA bill in the new Bipartisan Innovation Act.
An overvalued dollar is helping to exacerbate the country’s largest-ever trade deficit in goods. The U.S. is on pace for $1.1 trillion deficit in 2022.
A House Foreign Affairs Committee hearing warned against creating economic dead zones in rush to switch to renewables.
The Senate Armed Services Committee heard testimony this week from defense industry experts warning about the declining domestic market share for microelectronics.
The U.S. China Economic And Security Review Commission debated ways to better deal with China’s non-market economy in the WTO. Tariffs were part of the solution.
At a hearing by the U.S. China Economic and Security Review Commission, the Market Access Charge is brought up as a way to balance trade.
At a hearing by the U.S. China Economic and Security Review Commission, panelists agree that removing China from its Permanent Normal Trade Relations status with the U.S. is not (yet) in the cards.